LAMISILATE MONODOSE 1 %, solution for application cutaneous tube, 4 g
Active ingredients: Terbinafine, Terbinafine hydrochloride
Commercialized according to BDPM
Solutiontube, 4 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAMISILATE MONODOSE 1 %, solution pour application cutanée
- Pharmaceutical form
- solution
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) polyéthylène aluminium de 4 g
- Marketing authorisation holder
- KARO HEALTHCARE (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Mar 2007
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67758027CIP73770684CIP133400937706841Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TERBINAFINE (CHLORHYDRATE DE)solution | 11,25 mg · 1 g de solution | SA |
| TERBINAFINEsolution | 10,00 mg · 1 g de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.